CDH2 and osteosarcoma: PGM5‐AS1 reduction resulted in upregulated E‐cadherin expression, downregulated expression of N‐cadherin and Vimentin (Fig. 5B,C), and attenuated migration and invasion in osteosarcoma cells (Fig. 5D,E).